Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment

被引:300
作者
Andrews, Jonathan P. [1 ]
Marttala, Jaana [1 ]
Macarak, Edward [1 ,2 ]
Rosenbloom, Joel [1 ,2 ]
Uitto, Jouni [1 ,3 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Dermatol & Cutaneous Biol, 233 S 10th St,Suite 450 BLSB, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Joan & Joel Rosenbloom Res Ctr Fibrot Dis, 233 S 10th St,Suite 450 BLSB, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Jefferson Inst Mol Med, 233 S 10th St,Suite 450 BLSB, Philadelphia, PA 19107 USA
关键词
Fibrotic disease; Inflammation; Keloid; Collagen; TGF-beta; Wound healing; ENDOTHELIAL GROWTH-FACTOR; IMIQUIMOD 5-PERCENT CREAM; EXTRA DOMAIN-A; TGF-BETA; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; CELLULAR FIBRONECTIN; SUSCEPTIBILITY LOCI; HYPERTROPHIC SCARS; FIBROBLAST GROWTH;
D O I
10.1016/j.matbio.2016.01.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Keloids, fibroproliferative dermal tumors with effusive accumulation of extracellular matrix (ECM) components, particularly collagen, result from excessive expression of growth factors and cytokines. The etiology of keloids is unknown but they occur after dermal injury in genetically susceptible individuals, and they cause both physical and psychological distress for the affected individuals. Several treatment methods for keloids exist, including the combination therapy of surgical excision followed by intralesional steroid therapy, however, they have high recurrence rate regardless of the current treatment method. Improved understanding of the pathomechanisms leading to keloid formation will hopefully identify pathways that serve as specific targets to improve therapy for this devastating, currently intractable, disorder. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 97 条
[1]
Keloid pathogenesis and treatment [J].
Al-Attar, A ;
Mess, S ;
Thomassen, JM ;
Kauffman, CL ;
Davison, SP .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (01) :286-300
[2]
TREATMENT OF KELOID STERNOTOMY SCARS WITH 585 NM FLASHLAMP-PUMPED PULSED-DYE LASER [J].
ALSTER, TS ;
WILLIAMS, CM .
LANCET, 1995, 345 (8959) :1198-1200
[3]
Keloid Pathogenesis: Potential Role of Cellular Fibronectin with the EDA Domain [J].
Andrews, Jonathan P. ;
Marttala, Jaana ;
Macarak, Edward ;
Rosenbloom, Joel ;
Uitto, Jouni .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (07) :1921-1925
[4]
Premature Collagen Fibril Formation, Fibroblast-Mast Cell Interactions and Mast Cell-Mediated Phagocytosis of Collagen in Keloids [J].
Arbi, Sandra ;
Eksteen, Ehren Cronje ;
Oberholzer, Hester Magdalena ;
Taute, Helena ;
Bester, Megan Jean .
ULTRASTRUCTURAL PATHOLOGY, 2015, 39 (02) :95-103
[5]
KELOID FIBROBLASTS EXHIBIT AN ALTERED RESPONSE TO TGF-BETA [J].
BABU, M ;
DIEGELMANN, R ;
OLIVER, N .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (05) :650-655
[6]
KELOIDS [J].
BERMAN, B ;
BIELEY, HC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (01) :117-123
[7]
Berman B, 2009, J DRUGS DERMATOL, V8, P455
[8]
Berse B, 1999, CLIN EXP IMMUNOL, V115, P176
[9]
The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis [J].
Bettinger, DA ;
Yager, DR ;
Diegelmann, RF ;
Cohen, IK .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1996, 98 (05) :827-833
[10]
Neo-ligands for innate immune receptors and the etiology of sterile inflammatory disease [J].
Beutler, Bruce .
IMMUNOLOGICAL REVIEWS, 2007, 220 :113-128